{
    "title": "109_hr6123",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Helping Fill the Medicare Rx Gap Act \nof 2006''.\n\nSEC. 2. INCLUDING COSTS INCURRED BY THE INDIAN HEALTH SERVICE, A \n              FEDERALLY QUALIFIED HEALTH CENTER, AN AIDS DRUG \n              ASSISTANCE PROGRAM, CERTAIN HOSPITALS, OR A \n              PHARMACEUTICAL MANUFACTURER PATIENT ASSISTANCE PROGRAM IN \n              PROVIDING PRESCRIPTION DRUGS TOWARD THE ANNUAL OUT OF \n              POCKET THRESHOLD UNDER PART D.\n\n    (a) In General.--Section 1860D-2(b)(4)(C) of the Social Security \nAct (42 U.S.C. 1395w-102(b)(4)(C)) is amended--\n            (1) in clause (i), by striking ``and'' at the end;\n            (2) in clause (ii)--\n                    (A) by striking ``such costs shall be treated as \n                incurred only if'' and inserting ``subject to clause \n                (iii), such costs shall be treated as incurred if'';\n                    (B) by striking ``, under section 1860D-14, or \n                under a State Pharmaceutical Assistance Program''; and\n                    (C) by striking the period at the end and inserting \n                ``; and''; and\n            (3) by inserting after clause (ii) the following new \n        clause:\n                            ``(iii) such costs shall be treated as \n                        incurred and shall not be considered to be \n                        reimbursed under clause (ii) if such costs are \n                        borne or paid--\n                                    ``(I) under section 1860D-14;\n                                    ``(II) under a State Pharmaceutical \n                                Assistance Program;\n                                    ``(III) by the Indian Health \n                                Service, an Indian tribe or tribal \n                                organization, or an urban Indian \n                                organization (as defined in section 4 \n                                of the Indian Health Care Improvement \n                                Act);\n                                    ``(IV) by a federally qualified \n                                health center (as defined in section \n                                1861(aa)(4));\n                                    ``(V) under an AIDS Drug Assistance \n                                Program under part B of title XXVI of \n                                the Public Health Service Act;\n                                    ``(VI) by a subsection (d) hospital \n                                (as defined in section 1886(d)(1)(B)) \n                                that meets the requirements of clauses \n                                (i) and (ii) of section 340B(a)(4)(L) \n                                of the Public Health Service Act; or\n                                    ``(VII) by a pharmaceutical \n                                manufacturer patient assistance \n                                program, either directly or through the \n                                distribution or donation of covered \n                                part D drugs, which shall be valued at \n                                the negotiated price of such covered \n                                part D drug under the enrollee's \n                                prescription drug plan or MA-PD plan as \n                                of the date that the drug was \n                                distributed or donated.''.\n    (b) Effective Date.--The amendments made by subsection (a) shall \napply to costs incurred on or after January 1, 2006.\n\nSEC. 3. PROVIDING A SAFE HARBOR FOR PHARMACEUTICAL MANUFACTURER PATIENT \n              ASSISTANCE PROGRAMS.\n\n    (a) Safe Harbor.--Section 1128B(b)(3) of the Social Security Act \n(42 U.S.C. 1320a-7b(b)(3)) is amended--\n            (1) in subparagraph (G), by striking ``and'' at the end;\n            (2) in subparagraph (H), as added by section 237(d) of the \n        Medicare Prescription Drug, Improvement, and Modernization Act \n        of 2003 (Public Law 108-173; 117 Stat. 2213)--\n                    (A) by moving such subparagraph 2 ems to the left; \n                and\n                    (B) by striking the period at the end and inserting \n                a semicolon;\n            (3) by redesignating subparagraph (H), as added by section \n        431(a) of the Medicare Prescription Drug, Improvement, and \n        Modernization Act of 2003 (Public Law 108-173; 117 Stat. 2287), \n        as subparagraph (I);\n            (4) in subparagraph (I), as so redesignated--\n                    (A) by moving such subparagraph 2 ems to the left; \n                and\n                    (B) by striking the period at the end and inserting \n                ``; and''; and\n            (5) by adding at the end the following new subparagraph:\n            ``(J) any remuneration paid by a pharmaceutical \n        manufacturer patient assistance program, either in cash or \n        through the distribution or donation of covered Part D drugs \n        (as defined in section 1860D-2(e)), to an individual enrolled \n        in a prescription drug plan under part D of title XVIII or in \n        an MA-PD plan under part C of such title.''.\n    (b) Effective Date.--The amendments made by subsection (a) shall \napply to remuneration paid on or after January 1, 2006."
}